SCA
TECH icon

SAC Capital Advisors’s Bio-Techne TECH Stock Holding History

SAC Capital Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-12,984
Closed -$224K – 1942
2013
Q2 		$224K Buy
+12,984
New +$216K ﹤0.01% 1424

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SAC Capital Advisors's TECH Position: Q3 2013 in Review

SAC Capital Advisors sold out of Bio-Techne (TECH) in Q3 2013, closing a stake of 12,984 shares — an estimated $224K sold.

SAC Capital Advisors first reported a position in TECH in Q2 2013 and held it in 1 quarter. The position peaked at $224K in Q2 2013. 248 funds tracked by Wall St. Rank hold TECH as of Q3 2013.

  • SAC Capital Advisors reported no remaining Bio-Techne position as of Q3 2013 after selling out during the quarter.
  • SAC Capital Advisors sold 12,984 Bio-Techne shares in Q3 2013, an estimated $224K.
  • SAC Capital Advisors first reported a position in Bio-Techne in Q2 2013 and held it in 1 quarter.
  • SAC Capital Advisors's Bio-Techne position peaked at $224K in Q2 2013.
  • 248 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2013.

Based on SAC Capital Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.